These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35932547)

  • 1. Outcomes in Guillain-Barré Syndrome following a second therapeutic cycle - A single-centre retrospective observational study.
    Faustino P; Coutinho M; Brum M; Medeiros L; Ladeira F
    J Neurol Sci; 2022 Oct; 441():120368. PubMed ID: 35932547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and real-world outcomes of Guillain-Barré syndrome in the Philippines.
    I Espiritu A; Separa KJNJ; Milla FJC; Adiao KJB; Leochico CFD; Jamora RDG
    Neurol Res; 2021 Dec; 43(12):995-1004. PubMed ID: 34229572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of intravenous immunoglobulin retreatment amongst Guillain-Barré syndrome patients who poorly responded to initial IVIG cycle: a systematic review.
    Prado MB; Adiao KJB; Turalde CWR; Dasig DA
    Acta Neurol Belg; 2024 Aug; 124(4):1237-1250. PubMed ID: 38553651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of IV Immunoglobulin in Indian Children With Guillain-Barré Syndrome.
    Kalita J; Kumar M; Misra UK
    Pediatr Crit Care Med; 2019 Jul; 20(7):652-659. PubMed ID: 30985608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of Guillain-Barré syndrome following intravenous immunoglobulin compared to natural course.
    Kalita J; Misra UK; Chaudhary SK; Das M; Mishra A; Ranjan A; Kumar M
    Eur J Neurol; 2022 Oct; 29(10):3071-3080. PubMed ID: 35837807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and outcome of Guillain-Barre syndrome in Saudi Arabia: a multicenter, retrospective study.
    Alanazy MH; Bakry SS; Alqahtani A; AlAkeel NS; Alazwary N; Osman AM; Mustafa RA; Al-Harbi TM; Abdulmana SO; Amper AC; Aldughaythir Y; Ali AS; Makkawi S; Maglan A; Alamoudi L; Alsulaiman F; Alabdali M; AlShareef AA; Abuzinadah AR; Bamaga AK
    BMC Neurol; 2021 Jul; 21(1):275. PubMed ID: 34253174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of various therapeutic modalities for Guillain Barré syndrome in Assiut University Children Hospital.
    Mohy-Eldeen ZM; Ahmad AR; Mahran HH; Saad K
    Turk J Pediatr; 2020; 62(6):962-969. PubMed ID: 33372434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study.
    Verboon C; van den Berg B; Cornblath DR; Venema E; Gorson KC; Lunn MP; Lingsma H; Van den Bergh P; Harbo T; Bateman K; Pereon Y; Sindrup SH; Kusunoki S; Miller J; Islam Z; Hartung HP; Chavada G; Jacobs BC; Hughes RAC; van Doorn PA;
    J Neurol Neurosurg Psychiatry; 2020 Feb; 91(2):113-121. PubMed ID: 31586949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of plasma exchange versus intravenous immunoglobulin for the treatment of Guillain-Barré Syndrome: A double-blind, randomized clinical trial.
    Haridy NA; Shehab MM; Khedr EM
    Restor Neurol Neurosci; 2023; 41(5-6):203-217. PubMed ID: 38217554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, electrophysiological findings and evaluation of prognosis of patients with Guillain-Barré syndrome.
    Kılıç B; Güngör S; Özgör B
    Turk J Pediatr; 2019; 61(2):200-208. PubMed ID: 32077646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Guillain-Barré syndrome with plasmapheresis or immunoglobulin: our experience from a tertiary care institute in South India.
    Kishore CK; Vijayabhaskar J; Vishnu Vardhan R; Sainaresh VV; Sriramnaveen P; Sridhar AV; Varalaxmi B; Sandeep P; Ram R; Vengamma B; Siva Kumar V
    Ren Fail; 2014 Jun; 36(5):732-6. PubMed ID: 24593239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient characteristics and the effects of intravenous immunoglobulin in patients with Guillain-Barre syndrome.
    Guzey Aras Y; Tanik O; Dogan Güngen B; Kotan D
    Ideggyogy Sz; 2016 Nov; 69(11-12):389-395. PubMed ID: 29733556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intravenous immunoglobulin and plasmapheresis on nerve conduction parameters compared to the natural course of Guillain-Barré syndrome.
    Kalita J; Mahajan R; Kumar M
    J Clin Neurosci; 2024 Jul; 125():76-82. PubMed ID: 38759351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS).
    van Doorn PA
    Presse Med; 2013 Jun; 42(6 Pt 2):e193-201. PubMed ID: 23628447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome.
    van Doorn PA; Van den Bergh PYK; Hadden RDM; Avau B; Vankrunkelsven P; Attarian S; Blomkwist-Markens PH; Cornblath DR; Goedee HS; Harbo T; Jacobs BC; Kusunoki S; Lehmann HC; Lewis RA; Lunn MP; Nobile-Orazio E; Querol L; Rajabally YA; Umapathi T; Topaloglu HA; Willison HJ
    Eur J Neurol; 2023 Dec; 30(12):3646-3674. PubMed ID: 37814552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome.
    van Doorn PA; Van den Bergh PYK; Hadden RDM; Avau B; Vankrunkelsven P; Attarian S; Blomkwist-Markens PH; Cornblath DR; Goedee HS; Harbo T; Jacobs BC; Kusunoki S; Lehmann HC; Lewis RA; Lunn MP; Nobile-Orazio E; Querol L; Rajabally YA; Umapathi T; Topaloglu HA; Willison HJ
    J Peripher Nerv Syst; 2023 Dec; 28(4):535-563. PubMed ID: 37814551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin therapy for HIV-associated Guillain-Barré syndrome.
    Wang J; Zhang Y; Wang M; Ren Y; Tang M; Liu L; Zhou D
    Int Immunopharmacol; 2022 Nov; 112():109192. PubMed ID: 36155283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barré syndrome: a randomized study.
    El-Bayoumi MA; El-Refaey AM; Abdelkader AM; El-Assmy MM; Alwakeel AA; El-Tahan HM
    Crit Care; 2011 Jul; 15(4):R164. PubMed ID: 21745374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin and Guillain-Barré syndrome.
    Harel M; Shoenfeld Y
    Clin Rev Allergy Immunol; 2005 Dec; 29(3):281-7. PubMed ID: 16391403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2012 Jul; (7):CD002063. PubMed ID: 22786476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.